Items where Author is "Topp, Max S."

2015

Berges, Carsten and Bedke, Tanja and Stuehler, Claudia and Khanna, Nina and Zehnter, Sarah and Kruhm, Michaela and Winter, Nadine and Bargou, Ralf C. and Topp, Max S. and Einsele, Hermann and Chatterjee, Manik. (2015) Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs. Journal of Leukocyte Biology, 98 (6). pp. 1091-1105.

Stuehler, Claudia and Nowakowska, Justyna and Bernardini, Claudia and Topp, Max S. and Battegay, Manuel and Passweg, Jakob and Khanna, Nina. (2015) Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. The Journal of Infectious Disease, 211 (8). pp. 1251-1261.

2011

Stuehler, Claudia and Khanna, Nina and Bozza, Silvia and Zelante, Teresa and Moretti, Silvia and Kruhm, Michaela and Lurati, Sarah and Conrad, Barbara and Worschech, Eike and Stevanovi?, Stefan and Krappmann, Sven and Einsele, Hermann and Latgé, Jean-Paul and Loeffler, Juergen and Romani, Luigina and Topp, Max S.. (2011) Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood, Vol. 117, H. 22. pp. 5881-5891.

Khanna, Nina and Stuehler, Claudia and Conrad, Barbara and Lurati, Sarah and Krappmann, Sven and Einsele, Hermann and Berges, Carsten and Topp, Max S.. (2011) Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood, Vol. 118, H. 4. pp. 1121-1131.

2010

Engert, Andreas and Josting, Andreas and Haverkamp, Heinz and Villalobos, Matthias and Lohri, Andreas and Sökler, Martin and Zijlstra, Josée and Sturm, Isrid and Topp, Max S. and Rank, Andreas and Zenz, Thorsten and Vogelhuber, Martin and Nogova, Lucia and Borchmann, Peter and Fuchs, Michael and Flechtner, Hans-Henning and Diehl, Volker. (2010) Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma : results of the randomized placebo-controlled GHSG HD15EPO trial. Journal of clinical oncology, Vol. 28, H. 13. pp. 2239-2245.